Abstract
Despite improved treatment for HIV disease and FDA approved pre-exposure prophylaxis (PrEP) for HIV prevention in 2012, Washington DC continues to be an endemic city with an overall prevalence of 1.9% and 41% of new infections occurring in youth; almost double the national rate. The interest and uptake of PrEP in youth has been relatively understudied to date. This study sought to document the current level of awareness about and willingness to take PrEP in a sample of urban youth from our patient community, as well as changes in awareness between 2012 and 2018.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
